Piramal Pharma Limited Financial Overview
Piramal Pharma Limited's market cap is currently ₹224.11B. The company's EPS TTM is ₹-0.7; its P/E ratio is -925.86; and it has a dividend yield of 0.08%. Piramal Pharma Limited is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is ₹0.20. See an overview of income statement, balance sheet, and cash flow financials.
